Enzo Biochem, Inc. (ENZ)
NYSE: ENZ · IEX Real-Time Price · USD
1.160
+0.050 (4.50%)
Jul 12, 2024, 12:32 PM EDT - Market open

Enzo Biochem Cash Flow Statement

Millions USD. Fiscal year is Aug - Jul.
Year
20232022202120202019 2018 - 1994
Net Income
20.29-18.267.88-28.522.49
Upgrade
Depreciation & Amortization
2.682.832.652.783.04
Upgrade
Share-Based Compensation
3.152.341.641.771.79
Upgrade
Other Operating Activities
-63.09-3.5-11.786.79-2.51
Upgrade
Operating Cash Flow
-36.98-16.590.39-17.184.81
Upgrade
Capital Expenditures
-2.76-3.47-4.44-2.17-8.13
Upgrade
Acquisitions
101.740000
Upgrade
Change in Investments
028.7-30.0600
Upgrade
Investing Cash Flow
98.9825.22-34.5-2.17-8.13
Upgrade
Share Issuance / Repurchase
0.40.030.100.17
Upgrade
Debt Issued / Paid
-1.53-0.27-0.3474.03
Upgrade
Financing Cash Flow
-1.13-0.24-0.2474.19
Upgrade
Exchange Rate Effect
-0.11-0.060.010.07-0.02
Upgrade
Net Cash Flow
60.778.33-34.34-12.280.86
Upgrade
Free Cash Flow
-39.74-20.06-4.05-19.35-3.32
Upgrade
Free Cash Flow Margin
-127.93%-61.46%-3.44%-25.45%-4.09%
Upgrade
Free Cash Flow Per Share
-0.81-0.41-0.08-0.41-0.07
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).